Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MAPVIX: Mapping the Uterine Cervix Stiffness of Pregnant Women at Mid Gestation

NCT05858775 is registered in ClinicalTrials.gov with Pregnolia AG as lead sponsor.

NCT NCT05858775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05858775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MAPVIX: Mapping the Uterine Cervix Stiffness of Pregnant Women at Mid Gestation
Lead sponsor
Pregnolia AG
Phase
Observational
Overall status
Completed
Start date
July 5, 2023
Completion date
October 10, 2025
Enrollment
30 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cervix; pregnancy